Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine. MAIDENHEAD, United Kingdom, Sept. 11, 2026 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL; USOTC: CSLLY), today announced publication of pivotal Phase 3 study results for its MF59®-adjuvanted cell-based higher-dose...
ABEC Opens New Manufacturing Facility in Wilson, North Carolina
Grand Opening Ceremony Scheduled for September 24, 2026 BETHLEHEM, Pa., Sept. 10, 2026 /PRNewswire/ -- ABEC, a global leader in customized solutions and services for biopharmaceutical manufacturing, today announced the grand opening of its newest manufacturing facility in Wilson, North Carolina. The official ribbon-cutting ceremony and facility opening celebration will take...
Dr Hanan H. Balkhy Launches Candidacy for WHO Director-General, Pledges “A WHO the World Can Count On”
Nominated by the Kingdom of Saudi Arabia A physician trained in Saudi Arabia and the United States, with more than 30 years of experience spanning clinical medicine, academic research and international public health leadership WHO Regional Director for the Eastern Mediterranean sets out a three-part platform for a more trusted, prepared and accountable World Health Organization Record...
POMDOCTOR LIMITED to Participate in H.C. Wainwright’s 28th Annual Global Investment Conference
Virtual company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET GUANGZHOU, China, Sept. 10, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today announced that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September 14...
ZEISS announces commercial availability of bitoric hydrophobic monofocal IOL – the ZEISS AT LUCIA toric 721P
Launching at ESCRS in London, the world's first bitoric hydrophobic monofocal intraocular lens with a non-constant asphericity profile design expands the ZEISS LUCIA Family to treat cataracts while simultaneously correcting astigmatism. JENA, Germany, Sept. 10, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today the commercial availability of the ZEISS AT LUCIA toric...
TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection
— Phase IIb multicenter trial initiated, bringing this potential life-changing therapy closer to patients — SUZHOU, China, Sept. 10, 2026 /PRNewswire/ -- TenNor Therapeutics, a near-commercial-stage biotechnology company, today announced positive topline results from a Phase IIa proof-of-concept (POC) trial of rifaquizinone (TNP-2092), a first-in-class, triple-targeting drug candidate administered via intra-articular (IA) injection for the treatment of periprosthetic...
Nuritas Appoints Former Unilever North America President Kees Kruythoff as Board Chair
The 30-year industry veteran brings global scaling and commercialization expertise to biotech leader Nuritas. DUBLIN, Sept. 10, 2026 /PRNewswire/ -- Nuritas, a global leader in bioactive peptide discovery, today announced the appointment of Kees Kruythoff as Chair of its Board of Directors. The former Unilever Executive Committee member joins Nuritas at a pivotal moment in the company's mission...
Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing
SINGAPORE, Sept. 10, 2026 /PRNewswire/ -- Novo Holdings, a leading global healthcare and life sciences investor, today announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd. ("ForYou Medical"), a China-based contract development and manufacturing organisation (CDMO) specialising in advanced wound care products. GL Capital, one of China's leading healthcare-focused private equity firms, will remain the company's...
CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year
CordenPharma accelerates sterile injectable CDMO manufacturing expansion with €80 million multi-year investment in new facility and additional aseptic fill & finish lines BASEL, Switzerland, Sept. 10, 2026 /PRNewswire/ -- CordenPharma continues its ambitious long-term injectable CAPEX program at its FDA & EMA-approved Caponago (Milan), Italy site, reinforcing its position as a...
Dymax Launches BlueWave® FX Line Emitters to Boost Throughput in High-Speed Linear UV/Visible Curing
- New 75 mm and 150 mm line emitters deliver up to 4.2 W/cm² with 365/385/405 nm options and FX controller compatibility for scalable automation. SINGAPORE, Sept. 10, 2026 /PRNewswire/ -- Dymax, a global manufacturer of light-curing materials and equipment, today announced the BlueWave® FX Line Emitter series, purpose-built to deliver fast, uniform linear UV/Visible exposure in automated...
